SpineZone, a US-based provider of non-operative back and neck pain treatments, collected $12m today in a series A round co-led by Providence Ventures, the corporate venturing arm of healthcare provider Providence Health.
Investment firm Polaris Partners co-led the round with Providence, and it was filled out by venture capital firm Martin Ventures.
Founded in 2005, SpineZone provides personalised treatment programmes for musculoskeletal conditions that cause back and neck pain while minimising the need for surgery or prescription medication.
The company’s offering includes treatment clinics and an online platform through which users can access personalised guidance and instructions for at-home exercises.
The series A funding will enable SpineZone to enter new markets, expand its software to cover all musculoskeletal conditions and engage in more strategic partnerships with organisations in the healthcare industry.
SpineZone had already formed strategic partnerships with Providence Health in addition to health systems such as Sharp HealthCare and Scripps.